FDA’s Preparedness For Nanotech Debated At Public Meeting
This article was originally published in The Gray Sheet
Executive Summary
A former FDA deputy commissioner joined other speakers at an Oct. 10 meeting in urging the agency to seek additional expertise and resources in its oversight of products that rely on materials controllable at scales as small as one-billionth of a meter